Comparison of Current Regulatory Status for Gene-Based Vaccines in the U.S., Europe and Japan
Gene-based vaccines as typified by plasmid DNA vaccines and recombinant viral-vectored vaccines are expected as promising solutions against infectious diseases for which no effective prophylactic vaccines exist such as HIV, dengue virus, Ebola virus and malaria, and for which more improved vaccines...
Main Authors: | Yoshikazu Nakayama, Atsushi Aruga |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-03-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/3/1/186 |
Similar Items
-
Strategies for Vaccination: Conventional Vaccine Approaches Versus New-Generation Strategies in Combination with Adjuvants
by: Abdellatif Bouazzaoui, et al.
Published: (2021-01-01) -
Vaccines against Botulism
by: Grace Sundeen, et al.
Published: (2017-09-01) -
A Sneak Peek into COVID-19 Vaccines-Present Status
by: SWATHI GURAJALA
Published: (2021-03-01) -
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
by: Bowen Lu, et al.
Published: (2024-02-01) -
Plasmids for therapy and vaccination /
by: Schleef, M. (Martin)
Published: (2001)